Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
Author(s) -
Lucian L. Leape
Publication year - 1999
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.282.3.267
Subject(s) - medicine , pharmacist , psychological intervention , adverse effect , intensive care unit , emergency medicine , clinical pharmacy , medical emergency , pharmacy , family medicine , intensive care medicine , nursing
Pharmacist review of medication orders in the intensive care unit (ICU) has been shown to prevent errors, and pharmacist consultation has reduced drug costs. However, whether pharmacist participation in the ICU at the time of drug prescribing reduces adverse events has not been studied.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom